Please use this identifier to cite or link to this item: http://umt-ir.umt.edu.my:8080/handle/123456789/5002
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNurul Faziana Kamal-
dc.date.accessioned2017-03-26T07:55:48Z-
dc.date.available2017-03-26T07:55:48Z-
dc.date.issued2013-10-
dc.identifier.urihttp://hdl.handle.net/123456789/5002-
dc.description.abstractCurrent drugs in the market for atherosclerosis mostly involved the reduction of atherosclerotic progression by decreasing the plasma low density lipoprotein (LDL) levels. With prolonged use of this drug, it is reported to may cause liver failure. Meanwhile, drugs targeting on high density lipoprotein (HDL) in reducing/preventing the development of atherosclerosis are yet to be developed, although HDL plays an important role in reverse cholesterol transport (RCT). Potential targets in RCT have been identified to prevent atherosclerosis: scavenger receptor class B type 1 (SR-B1) and peroxisome proliferator response elements (PPRE). This study was therefore carried-out to explore new peroxisome proliferator activated receptor (PPAR) ligand agonists for the activation of these potential targets, from sponge-derived fungi, as potential drugs for atherosclerosis.en_US
dc.language.isoenen_US
dc.publisherTerengganu: Universiti Malaysia Terengganuen_US
dc.relation.ispartofseries;RC 692 .N82 2013-
dc.subjectRC 692 .N82 2013en_US
dc.subjectNurul Faziana Kamalen_US
dc.subjectTesis PPSA 2013en_US
dc.subjectAtherosclerosisen_US
dc.subjectAtherosclerotic plaqueen_US
dc.titleExtracts of sponge-derived fungi as potential anti-atherosclerotic agenten_US
dc.typeThesisen_US
Appears in Collections:Pusat Pengajian Sains Asas

Files in This Item:
File Description SizeFormat 
RC 692 .N82 2013 Abstract.pdf201.75 kBAdobe PDFView/Open
RC 692 .N82 2013 FullText.pdf
  Restricted Access
2.23 MBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.